Skip to main navigation Skip to search Skip to main content

Pentoxifylline downregulates nitric oxide and tumor necrosis factor-α induced by mycobacterial lipoarabinomannan in a macrophage cell line

  • Eunkyue Park
  • , Georgia Schuller-Levis
  • , Seung Yong Park
  • , Jun Hua Jia
  • , William R. Levis
  • , C. Kim
  • New York State Office for People with Developmental Disabilities
  • Northwell Health System

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Pentoxifylline (PTX), a phosphodiesterase inhibitor, is known to downregulate tumor necrosis factor-alpha (TNF-α) secretion induced by lipopolysacchride (LPS) and gamma interferon (IFN-γ). We have had limited success in treating leprosy reactions, including erythema nodosum leprosum (ENL), in which TNF-α has been identified as a major proinflammatory cytokine. PTX inhibited production of NO (IC50 ≅ 1.0 mg/ml) and TNF-α (IC50 ≅ 0.05 mg/ml) in a dose-dependent fashion. As little as 0.5 mg/ml of PTX decreased NO production and 0.01 mg/ml of PTX inhibited TNF-α production. Western blot analyses demonstrated that iNOS was suppressed by PTX. Northern blot analyses showed significant reduction of TNF-α mRNA. We conclude that PTX is an effective inhibitor of lipoarabinomannan (LAM)-induced TNF-α production at both the product and transcriptional levels in our macrophage cell line. PTX also showed moderate inhibition of NO at the product level as well as translation of iNOS.

Original languageEnglish
Pages (from-to)225-233
Number of pages9
JournalInternational Journal of Leprosy and Other Mycobacterial Diseases
Volume69
Issue number3
StatePublished - 2001

Fingerprint

Dive into the research topics of 'Pentoxifylline downregulates nitric oxide and tumor necrosis factor-α induced by mycobacterial lipoarabinomannan in a macrophage cell line'. Together they form a unique fingerprint.

Cite this